A Rare Case of Tongue Neoplasia Treated Successfully in a Patient With B-Cell Acute Lymphoblastic Leukemia Following Allogeneic Hematopoietic Stem Cell Transplantation.

Abstract

ABSTRACT:

Abnormal change on the tongue is a potential complication after allogeneic hematopoietic stem cell transplantation (allo-HSCT). The exact pathogenesis remains unclear and several risk factors include chemoradiotherapy, infection, graft-versus-host disease, disease relapse, and secondary malignancy. Our case described a 42-year-old woman with B-cell acute lymphoblastic leukemia treated by allo-HSCT 2 months later followed by a rare and atypical tongue neoplasia without oral pain, dysphagia, and dysgeusia. The biopsy was operated which showed granulation tissue with no evidence on typical graft-versus-host disease or malignancy, and no specific infection had been identified. Cyclosporine and mycophenolate mofetil, which were used for immunosuppression after allo-HSCT accompanying with the rapid growth of the tongue neoplasia, was then replaced by sirolimus. One month later, the patient underwent a complete remission unexpectedly.

• Authors: Xi Qiu, Teng Yu, Yang Xu
• Journal: The Journal of craniofacial surgery (J Craniofac Surg) 2021 Jul-Aug 01 Vol. 32 Issue 5 Pg. e452-e454 ISSN: 1536-3732 [Electronic] United States
• PMID: 33405438 (Publication Type: Case Reports, Journal Article)
• Copyright: Copyright © 2020 by Mutaz B. Habal, MD.

Topics

• Adult
• B-Lymphocytes
• Female
• Hematopoietic Stem Cell Transplantation
• Humans
• Precursor Cell Lymphoblastic Leukemia-Lymphoma (therapy)
• Tongue
• Transplantation, Homologous